Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
# START YOAST BLOCK # --------------------------- User-agent: * Disallow: Sitemap: https://veralox.com/sitemap_index.xml # --------------------------- # END YOAST |
Title | Home - Veralox |
Description | Developing new therapies for life-threatening immuno-inflammatory About Veralox Meet the Team Our Approach Pipeline Publications Company News Contact Search for: Search Developing new therapies for life-threatening immun |
Keywords | N/A |
WebSite | veralox.com |
Host IP | 172.104.216.183 |
Location | - |
Site | Rank |
US$3,713,239
Last updated: 2023-05-02 05:43:52
veralox.com has Semrush global rank of 2,850,424. veralox.com has an estimated worth of US$ 3,713,239, based on its estimated Ads revenue. veralox.com receives approximately 428,451 unique visitors each day. Its web server is located in -, with IP address 172.104.216.183. According to SiteAdvisor, veralox.com is safe to visit. |
Purchase/Sale Value | US$3,713,239 |
Daily Ads Revenue | US$3,428 |
Monthly Ads Revenue | US$102,829 |
Yearly Ads Revenue | US$1,233,938 |
Daily Unique Visitors | 28,564 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
veralox.com. | A | 599 | IP: 172.104.216.183 |
veralox.com. | NS | 3600 | NS Record: ns74.domaincontrol.com. |
veralox.com. | NS | 3600 | NS Record: ns73.domaincontrol.com. |
veralox.com. | MX | 3600 | MX Record: 10 veralox.com.1.0001.arsmtp.com. |
veralox.com. | MX | 3600 | MX Record: 20 veralox.com.2.0001.arsmtp.com. |
veralox.com. | TXT | 3600 | TXT Record: v=spf1 include:spf.protection.outlook.com include:veralox-com.spf.smtp25.com -all |
veralox.com. | TXT | 3600 | TXT Record: iUmUHyGOHiRygtSn+BlE4A== |
About Veralox Meet the Team Our Approach Pipeline Publications Company News Contact Search for: Search Developing new therapies for life-threatening immuno-inflammatory diseases Veralox is a clinical stage company developing drug products targeting the 12-Lipoxygenase pathway The Target 12-Lipoxygenase 12-lipoxygenase (12-LOX) is an enzyme that oxidizes fatty acids, generates proinflammatory metabolites and has been implicated in a myriad of diseases including Heparin-Induced Thrombocytopenia (HIT) and Type 1 Diabetes (T1D). We are developing therapies for these diseases with a clinical program in HIT, preclinical program in T1D and discovery research aimed at expanding our 12-LOX inhibitors to additional diseases. Learn More about the Target Treatment Approach Heparin-Induced Thrombocytopenia (HIT) HIT is a deadly syndrome characterized by hyperactivated platelets and a devastating pro-thrombotic state. Targeting 12-LOX inhibits the production of 12-HETE, a proinflammatory metabolite |
HTTP/1.1 301 Moved Permanently Server: nginx Date: Sun, 24 Oct 2021 17:04:04 GMT Content-Type: text/html; charset=UTF-8 Content-Length: 0 Connection: keep-alive X-Redirect-By: WordPress Location: https://veralox.com/ Cache-Control: max-age=2592000 Expires: Tue, 23 Nov 2021 14:58:04 GMT Age: 7559 X-Cache: HIT HTTP/2 200 server: nginx date: Sun, 24 Oct 2021 17:04:04 GMT content-type: text/html; charset=utf-8 content-length: 21682 vary: Accept-Encoding cache-provider: CLOUDWAYS-CACHE-DE last-modified: Sat, 23 Oct 2021 21:10:17 GMT vary: Accept-Encoding cache-control: max-age=2592000 expires: Tue, 23 Nov 2021 13:42:54 GMT age: 12070 x-cache: HIT accept-ranges: bytes |
Domain Name: VERALOX.COM Registry Domain ID: 2236264685_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2020-03-07T11:27:06Z Creation Date: 2018-03-06T23:01:24Z Registry Expiry Date: 2022-03-06T23:01:24Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS73.DOMAINCONTROL.COM Name Server: NS74.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-12T23:32:51Z <<< |